Cargando…

In Reply to ‘Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?’

Detalles Bibliográficos
Autores principales:	De Vriese, An S., Reynders, Marijke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the National Kidney Foundation, Inc. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320694/ https://www.ncbi.nlm.nih.gov/pubmed/32603712 http://dx.doi.org/10.1053/j.ajkd.2020.06.005

Ejemplares similares

Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?
por: Dudreuilh, Caroline, et al.
Publicado: (2020)

IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis
por: De Vriese, An S., et al.
Publicado: (2020)

SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply
por: Teng, Jialin, et al.
Publicado: (2021)

Longevity and Clinical Effectiveness of the Humoral and Cellular Responses to SARS-CoV-2 Vaccination in Hemodialysis Patients
por: De Vriese, An S., et al.
Publicado: (2022)

Serological assays for delayed SARS-CoV-2 case identification – Author's reply
por: Pallett, Scott J C, et al.
Publicado: (2020)

Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays
por: Tian, Ying, et al.
Publicado: (2020)

SARS-CoV-2 serological cross-reactivity with autoantibodies
por: Choy, Kay Weng
Publicado: (2021)

SARS-CoV-2 seroprevalence in Spain – Authors' reply
por: Pollán, Marina, et al.
Publicado: (2020)

Serological assays for delayed SARS-CoV-2 case identification
por: Choy, Kay Weng
Publicado: (2020)

Cadaveric donor specimens and serological testing for SARS-CoV-2
por: Yeang, Malinna, et al.
Publicado: (2022)

Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in haemodialysis patients
por: De Vriese, An S, et al.
Publicado: (2021)

SARS-CoV-2 infection in conjunctival tissue – Authors' reply
por: Hui, Kenrie PY, et al.
Publicado: (2020)

Neuropathology associated with SARS-CoV-2 infection – Authors' reply
por: von Weyhern, Claus Hann, et al.
Publicado: (2021)

Challenges in interpreting SARS-CoV-2 serological results in African countries
por: Nkuba Ndaye, Antoine, et al.
Publicado: (2021)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply
por: Voysey, Merryn, et al.
Publicado: (2020)

Reply to “SARS-CoV-2-associated Takotsubo is not necessarily triggered by the infection”
por: Sattar, Yasar, et al.
Publicado: (2020)

Stability of SARS-CoV-2 in different environmental conditions – Authors' reply
por: Chin, Alex W H, et al.
Publicado: (2020)

Transmission of SARS-CoV-2: still up in the air – Authors' reply
por: Greenhalgh, Trisha, et al.
Publicado: (2022)

Practical measures for SARS-CoV-2 infection prevention – Authors' reply
por: Llibre, Josep M, et al.
Publicado: (2022)

SARS-CoV-2 rapid antigen detection tests – Authors' reply
por: Peeling, Rosanna W, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees – Authors' reply
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing – Authors' reply
por: Lohse, Stefan, et al.
Publicado: (2020)

Reply to: The role of pets in SARS-CoV-2 transmission: an exploratory analysis
por: Galmiche, Simon, et al.
Publicado: (2022)

Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
por: Pallett, Scott J C, et al.
Publicado: (2021)

Reply to Philip et al.: Aerosol Transmission of SARS-CoV-2: Inhalation as well as Exhalation Matters for COVID-19
por: Echternach, Matthias, et al.
Publicado: (2021)

Neutrophils as a pallbearer for SARS-CoV-2 disease burden – Authors’ reply
por: Lutter, René, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Unclear conclusions on SARS-CoV-2 elimination versus mitigation – Authors' reply
por: Oliu-Barton, Miquel, et al.
Publicado: (2021)

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story – Authors' reply
por: Ozonoff, Al, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
por: Alexander, James L, et al.
Publicado: (2021)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals – Authors' reply
por: Lalvani, Ajit, et al.
Publicado: (2022)

Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
por: Perez-Saez, Javier, et al.
Publicado: (2021)

Misclassification bias in estimating clinical severity of SARS-CoV-2 variants – Authors' reply
por: Nyberg, Tommy, et al.
Publicado: (2022)

Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
por: Lucchini, Matteo, et al.
Publicado: (2020)

Association of SARS-CoV-2 renal tropism with acute kidney injury – Authors' reply
por: Braun, Fabian, et al.
Publicado: (2020)

The ability of the neonatal immune response to handle SARS-CoV-2 infection – Authors' reply
por: Gale, Chris, et al.
Publicado: (2021)

Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? – Authors' reply
por: Tsang, Nicole Ngai Yung, et al.
Publicado: (2021)

Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients”
por: Marcus-Mandelblit, Nufar, et al.
Publicado: (2023)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

Misuse of SARS-CoV-2 testing in symptomatic health-care staff in the UK – Authors' reply
por: Black, James R M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l5to5fq91qdm11ch8vr01bcto7